(Q28210329)

English

The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2

scientific article (publication date: 15 June 2001)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2 (English)

0 references

2

A Karlsson

0 references

Claes Dahlgren

series ordinal

6

object named as

C Dahlgren

0 references

author name string

T Christophe

series ordinal

1

0 references

C Dugave

series ordinal

3

0 references

M J Rabiet

series ordinal

4

0 references

F Boulay

series ordinal

5

0 references

language of work or name

English

0 references

publication date

15 June 2001

0 references

published in

Journal of Biological Chemistry

0 references

volume

276

0 references

page(s)

21585-93

0 references

issue

24

0 references

Identifiers

DOI

10.1074/JBC.M007769200

0 references

PubMed ID

11285256

0 references

(Q28210329)

The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)